managed care implications of the expanding role of parp inhibitors in oncology
Published 3 years ago • 77 plays • Length 1:32:38Download video MP4
Download video MP3
Similar videos
-
34:13
expert views on the evolving role of parp inhibitors in the treatment of ovarian cancer
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
1:13:00
expanding the benefits of parp inhibitors to more patients with breast cancer and earlier settings
-
2:38
assessing the role of parp inhibitors and immunotherapy in ovarian cancer
-
58:12
enhancing personalized medicine in ovarian cancer: advances in parp inhibition and novel modalities
-
6:36
role of parp inhibition in ovarian cancer
-
40:57
clinical advances in ovarian cancer: exploring the expanding role of parp inhibitors in the treat...
-
3:58
dana chase, md, considers the role of parp inhibitors in advanced ovarian cancer today
-
58:44
what’s new with parp inhibitors and ovarian cancer?
-
25:30
innovative and emerging trials in ovarian cancer
-
6:21
treating ovarian cancer with niraparib - a patient perspective
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
23:32
role of parp inhibitor in ovarian cancer dr. thomas herzog
-
1:01:32
pharmacy perspectives on parp inhibitor therapy in ovarian cancer care
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
3:44
the future role of parp inhibition in ovarian cancer
-
3:30
2020 in review: olaparib & rucaparib, fda approval | ask a prostate expert, mark scholz, md
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
0:56
dr. muss on the role of parp inhibitors in breast cancer
-
5:06
ovarian cancer: the role of parp inhibitors and beyond
-
0:47
dr. morgan on the role of parp inhibitors in prostate cancer
-
1:00
dr. morgan discusses the impact of parp inhibitors in prostate cancer